MedTrace Logo

Multicenter Blood Culture Quality Improvement

NCT01413555 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14889

Last updated 2015-06-04

No results posted yet for this study

Summary

False positive blood culture results due to specimen contamination with bacteria inhabiting patients' skin is a common problem in emergency departments (EDs) in the United States. Contaminated blood cultures lead to patient harm through unnecessary hospitalizations and ED visits, delays in surgery, unneeded antibiotics, and unnecessary procedures. The investigators have developed a multifaceted quality improvement improvement bundle (The Blood Culture QI Program) designed to minimize blood culture contamination in the ED. In this study, the investigators will implement the quality improvement bundle in six community hospital EDs and evaluate its effectiveness at reducing contamination.

Conditions

  • Bacteremia

Interventions

OTHER

Blood Culture QI Program

The Blood Culture QI Program contains four components:(1) education: content knowledge and standardized experiential training on sterile technique designed for ED nurses; (2) process redesign: conversion of blood culture collection from a clean to a sterile technique using the Blood Culture Sterile Kit; (3) a checklist outlining optimal use of the Kit; (4) feedback of blood culture contamination rates to ED nurses who collect them.

Sponsors & Collaborators

  • Community Health Network

    collaborator OTHER

  • CareFusion

    collaborator INDUSTRY

  • Vanderbilt University

    lead OTHER

Principal Investigators

  • Wesley H. Self, MD, MPH · Vanderbilt University Medical Center

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2013-03-31
Completion
2013-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01413555 on ClinicalTrials.gov